nodes	percent_of_prediction	percent_of_DWPC	metapath
Carfilzomib—PSMB10—respiratory system—chronic obstructive pulmonary disease	0.0367	0.112	CbGeAlD
Carfilzomib—PSMB10—lung—chronic obstructive pulmonary disease	0.0195	0.0593	CbGeAlD
Carfilzomib—PSMB8—bronchus—chronic obstructive pulmonary disease	0.0194	0.0592	CbGeAlD
Carfilzomib—PSMB1—respiratory system—chronic obstructive pulmonary disease	0.0182	0.0555	CbGeAlD
Carfilzomib—PSMB2—respiratory system—chronic obstructive pulmonary disease	0.0178	0.0542	CbGeAlD
Carfilzomib—PSMB8—trachea—chronic obstructive pulmonary disease	0.0175	0.0532	CbGeAlD
Carfilzomib—PSMB5—bronchus—chronic obstructive pulmonary disease	0.0172	0.0523	CbGeAlD
Carfilzomib—PSMB5—smooth muscle tissue—chronic obstructive pulmonary disease	0.0168	0.0512	CbGeAlD
Carfilzomib—PSMB2—connective tissue—chronic obstructive pulmonary disease	0.0157	0.0477	CbGeAlD
Carfilzomib—PSMB5—trachea—chronic obstructive pulmonary disease	0.0154	0.047	CbGeAlD
Carfilzomib—PSMB1—bronchus—chronic obstructive pulmonary disease	0.015	0.0457	CbGeAlD
Carfilzomib—PSMB1—smooth muscle tissue—chronic obstructive pulmonary disease	0.0147	0.0447	CbGeAlD
Carfilzomib—PSMB2—bronchus—chronic obstructive pulmonary disease	0.0146	0.0446	CbGeAlD
Carfilzomib—PSMB2—smooth muscle tissue—chronic obstructive pulmonary disease	0.0143	0.0436	CbGeAlD
Carfilzomib—PSMB1—trachea—chronic obstructive pulmonary disease	0.0135	0.041	CbGeAlD
Carfilzomib—PSMB2—trachea—chronic obstructive pulmonary disease	0.0132	0.0401	CbGeAlD
Carfilzomib—PSMB8—lung—chronic obstructive pulmonary disease	0.0125	0.0382	CbGeAlD
Carfilzomib—PSMB5—lung—chronic obstructive pulmonary disease	0.0111	0.0337	CbGeAlD
Carfilzomib—Hypercalcaemia—Aminophylline—chronic obstructive pulmonary disease	0.011	0.0254	CcSEcCtD
Carfilzomib—PSMB1—lung—chronic obstructive pulmonary disease	0.00968	0.0295	CbGeAlD
Carfilzomib—PSMB2—lung—chronic obstructive pulmonary disease	0.00945	0.0288	CbGeAlD
Carfilzomib—Renal failure acute—Roflumilast—chronic obstructive pulmonary disease	0.00898	0.0208	CcSEcCtD
Carfilzomib—Lopinavir—CYP1A2—chronic obstructive pulmonary disease	0.00698	0.543	CrCbGaD
Carfilzomib—Myocardial ischaemia—Salbutamol—chronic obstructive pulmonary disease	0.00681	0.0158	CcSEcCtD
Carfilzomib—Pneumonia—Roflumilast—chronic obstructive pulmonary disease	0.00643	0.0149	CcSEcCtD
Carfilzomib—Ritonavir—CYP1A2—chronic obstructive pulmonary disease	0.00587	0.457	CrCbGaD
Carfilzomib—Cardiac disorder—Roflumilast—chronic obstructive pulmonary disease	0.00532	0.0123	CcSEcCtD
Carfilzomib—Pain in extremity—Tiotropium—chronic obstructive pulmonary disease	0.00521	0.0121	CcSEcCtD
Carfilzomib—Hypokalaemia—Aminophylline—chronic obstructive pulmonary disease	0.00503	0.0117	CcSEcCtD
Carfilzomib—Back pain—Roflumilast—chronic obstructive pulmonary disease	0.00483	0.0112	CcSEcCtD
Carfilzomib—Muscle spasms—Roflumilast—chronic obstructive pulmonary disease	0.0048	0.0111	CcSEcCtD
Carfilzomib—Cardiac failure congestive—Formoterol—chronic obstructive pulmonary disease	0.00464	0.0107	CcSEcCtD
Carfilzomib—Cardiac failure congestive—Arformoterol—chronic obstructive pulmonary disease	0.00464	0.0107	CcSEcCtD
Carfilzomib—Lymphopenia—Prednisone—chronic obstructive pulmonary disease	0.00446	0.0103	CcSEcCtD
Carfilzomib—Hyperglycaemia—Aminophylline—chronic obstructive pulmonary disease	0.00431	0.00998	CcSEcCtD
Carfilzomib—Neuritis—Prednisolone—chronic obstructive pulmonary disease	0.0042	0.00974	CcSEcCtD
Carfilzomib—Upper respiratory tract infection—Tiotropium—chronic obstructive pulmonary disease	0.00419	0.0097	CcSEcCtD
Carfilzomib—Hyperglycaemia—Tiotropium—chronic obstructive pulmonary disease	0.00407	0.00941	CcSEcCtD
Carfilzomib—Infection—Roflumilast—chronic obstructive pulmonary disease	0.00405	0.00938	CcSEcCtD
Carfilzomib—Renal failure—Tiotropium—chronic obstructive pulmonary disease	0.00395	0.00915	CcSEcCtD
Carfilzomib—Hypokalaemia—Arformoterol—chronic obstructive pulmonary disease	0.00383	0.00887	CcSEcCtD
Carfilzomib—Hypokalaemia—Formoterol—chronic obstructive pulmonary disease	0.00383	0.00887	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Roflumilast—chronic obstructive pulmonary disease	0.00371	0.0086	CcSEcCtD
Carfilzomib—Aspartate aminotransferase increased—Montelukast—chronic obstructive pulmonary disease	0.00371	0.0086	CcSEcCtD
Carfilzomib—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.00369	0.00854	CcSEcCtD
Carfilzomib—Hypokalaemia—Salbutamol—chronic obstructive pulmonary disease	0.00362	0.00837	CcSEcCtD
Carfilzomib—Oedema peripheral—Tiotropium—chronic obstructive pulmonary disease	0.00355	0.00823	CcSEcCtD
Carfilzomib—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.00354	0.0082	CcSEcCtD
Carfilzomib—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.00351	0.00814	CcSEcCtD
Carfilzomib—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.00348	0.00807	CcSEcCtD
Carfilzomib—Upper respiratory tract infection—Formoterol—chronic obstructive pulmonary disease	0.00338	0.00783	CcSEcCtD
Carfilzomib—Upper respiratory tract infection—Arformoterol—chronic obstructive pulmonary disease	0.00338	0.00783	CcSEcCtD
Carfilzomib—Upper respiratory tract infection—Montelukast—chronic obstructive pulmonary disease	0.00331	0.00767	CcSEcCtD
Carfilzomib—Hyperglycaemia—Arformoterol—chronic obstructive pulmonary disease	0.00328	0.0076	CcSEcCtD
Carfilzomib—Hyperglycaemia—Formoterol—chronic obstructive pulmonary disease	0.00328	0.0076	CcSEcCtD
Carfilzomib—Acute coronary syndrome—Arformoterol—chronic obstructive pulmonary disease	0.0032	0.0074	CcSEcCtD
Carfilzomib—Acute coronary syndrome—Formoterol—chronic obstructive pulmonary disease	0.0032	0.0074	CcSEcCtD
Carfilzomib—Pneumonia—Montelukast—chronic obstructive pulmonary disease	0.00319	0.0074	CcSEcCtD
Carfilzomib—Upper respiratory tract infection—Salbutamol—chronic obstructive pulmonary disease	0.00319	0.00739	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Montelukast—chronic obstructive pulmonary disease	0.00311	0.00721	CcSEcCtD
Carfilzomib—Hyperglycaemia—Salbutamol—chronic obstructive pulmonary disease	0.0031	0.00717	CcSEcCtD
Carfilzomib—Neuritis—Prednisone—chronic obstructive pulmonary disease	0.00306	0.00708	CcSEcCtD
Carfilzomib—Back pain—Tiotropium—chronic obstructive pulmonary disease	0.00304	0.00703	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Salbutamol—chronic obstructive pulmonary disease	0.003	0.00695	CcSEcCtD
Carfilzomib—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00292	0.00677	CcSEcCtD
Carfilzomib—Oedema peripheral—Formoterol—chronic obstructive pulmonary disease	0.00287	0.00664	CcSEcCtD
Carfilzomib—Oedema peripheral—Arformoterol—chronic obstructive pulmonary disease	0.00287	0.00664	CcSEcCtD
Carfilzomib—Hypoaesthesia—Montelukast—chronic obstructive pulmonary disease	0.00284	0.00657	CcSEcCtD
Carfilzomib—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00279	0.00646	CcSEcCtD
Carfilzomib—Cough—Tiotropium—chronic obstructive pulmonary disease	0.00274	0.00635	CcSEcCtD
Carfilzomib—PSMB9—Dexamethasone—Prednisone—chronic obstructive pulmonary disease	0.00274	0.132	CbGdCrCtD
Carfilzomib—PSMB9—Betamethasone—Prednisone—chronic obstructive pulmonary disease	0.00274	0.132	CbGdCrCtD
Carfilzomib—Hypoaesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00273	0.00633	CcSEcCtD
Carfilzomib—ABCB1—respiratory system—chronic obstructive pulmonary disease	0.00272	0.00828	CbGeAlD
Carfilzomib—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.00271	0.00628	CcSEcCtD
Carfilzomib—Cardiac disorder—Arformoterol—chronic obstructive pulmonary disease	0.0027	0.00626	CcSEcCtD
Carfilzomib—Cardiac disorder—Formoterol—chronic obstructive pulmonary disease	0.0027	0.00626	CcSEcCtD
Carfilzomib—Infection—Aminophylline—chronic obstructive pulmonary disease	0.0027	0.00625	CcSEcCtD
Carfilzomib—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00269	0.00624	CcSEcCtD
Carfilzomib—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.00267	0.00619	CcSEcCtD
Carfilzomib—PSMB9—Dexamethasone—Prednisolone—chronic obstructive pulmonary disease	0.00267	0.129	CbGdCrCtD
Carfilzomib—PSMB9—Betamethasone—Prednisolone—chronic obstructive pulmonary disease	0.00267	0.129	CbGdCrCtD
Carfilzomib—Cardiac disorder—Montelukast—chronic obstructive pulmonary disease	0.00265	0.00613	CcSEcCtD
Carfilzomib—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00259	0.006	CcSEcCtD
Carfilzomib—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.00259	0.006	CcSEcCtD
Carfilzomib—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00255	0.00591	CcSEcCtD
Carfilzomib—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.00255	0.00591	CcSEcCtD
Carfilzomib—Infection—Tiotropium—chronic obstructive pulmonary disease	0.00255	0.0059	CcSEcCtD
Carfilzomib—Cardiac failure congestive—Prednisolone—chronic obstructive pulmonary disease	0.00251	0.00582	CcSEcCtD
Carfilzomib—Chills—Salbutamol—chronic obstructive pulmonary disease	0.00247	0.00571	CcSEcCtD
Carfilzomib—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.00246	0.00569	CcSEcCtD
Carfilzomib—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.00245	0.00568	CcSEcCtD
Carfilzomib—Back pain—Formoterol—chronic obstructive pulmonary disease	0.00245	0.00568	CcSEcCtD
Carfilzomib—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.00244	0.00564	CcSEcCtD
Carfilzomib—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.00244	0.00564	CcSEcCtD
Carfilzomib—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00242	0.00561	CcSEcCtD
Carfilzomib—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.00239	0.00553	CcSEcCtD
Carfilzomib—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.00236	0.00547	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.00233	0.00541	CcSEcCtD
Carfilzomib—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.00232	0.00537	CcSEcCtD
Carfilzomib—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.00231	0.00536	CcSEcCtD
Carfilzomib—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.0023	0.00533	CcSEcCtD
Carfilzomib—Cough—Arformoterol—chronic obstructive pulmonary disease	0.00221	0.00512	CcSEcCtD
Carfilzomib—Cough—Formoterol—chronic obstructive pulmonary disease	0.00221	0.00512	CcSEcCtD
Carfilzomib—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00219	0.00508	CcSEcCtD
Carfilzomib—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.00219	0.00507	CcSEcCtD
Carfilzomib—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.00219	0.00507	CcSEcCtD
Carfilzomib—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	0.00217	0.00502	CcSEcCtD
Carfilzomib—Cough—Montelukast—chronic obstructive pulmonary disease	0.00217	0.00502	CcSEcCtD
Carfilzomib—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.00216	0.005	CcSEcCtD
Carfilzomib—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.00216	0.005	CcSEcCtD
Carfilzomib—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00215	0.00498	CcSEcCtD
Carfilzomib—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.00211	0.00489	CcSEcCtD
Carfilzomib—Cough—Salbutamol—chronic obstructive pulmonary disease	0.00209	0.00484	CcSEcCtD
Carfilzomib—PSMB8—Medrysone—Prednisolone—chronic obstructive pulmonary disease	0.00209	0.1	CbGdCrCtD
Carfilzomib—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.00207	0.00478	CcSEcCtD
Carfilzomib—Infection—Arformoterol—chronic obstructive pulmonary disease	0.00205	0.00476	CcSEcCtD
Carfilzomib—Infection—Formoterol—chronic obstructive pulmonary disease	0.00205	0.00476	CcSEcCtD
Carfilzomib—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.00204	0.00472	CcSEcCtD
Carfilzomib—Infection—Montelukast—chronic obstructive pulmonary disease	0.00201	0.00466	CcSEcCtD
Carfilzomib—ABCB1—trachea—chronic obstructive pulmonary disease	0.00201	0.00612	CbGeAlD
Carfilzomib—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.00198	0.00459	CcSEcCtD
Carfilzomib—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.00198	0.00458	CcSEcCtD
Carfilzomib—Infection—Salbutamol—chronic obstructive pulmonary disease	0.00194	0.00449	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00188	0.00436	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00188	0.00436	CcSEcCtD
Carfilzomib—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00187	0.00433	CcSEcCtD
Carfilzomib—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00187	0.00433	CcSEcCtD
Carfilzomib—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.00186	0.00431	CcSEcCtD
Carfilzomib—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00186	0.00431	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00185	0.00427	CcSEcCtD
Carfilzomib—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00184	0.00427	CcSEcCtD
Carfilzomib—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00184	0.00427	CcSEcCtD
Carfilzomib—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00183	0.00424	CcSEcCtD
Carfilzomib—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.00183	0.00423	CcSEcCtD
Carfilzomib—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.0018	0.00416	CcSEcCtD
Carfilzomib—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00178	0.00413	CcSEcCtD
Carfilzomib—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00178	0.00413	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00178	0.00412	CcSEcCtD
Carfilzomib—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00177	0.0041	CcSEcCtD
Carfilzomib—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00177	0.0041	CcSEcCtD
Carfilzomib—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00177	0.0041	CcSEcCtD
Carfilzomib—Pain—Formoterol—chronic obstructive pulmonary disease	0.00177	0.0041	CcSEcCtD
Carfilzomib—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00177	0.00409	CcSEcCtD
Carfilzomib—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00175	0.00404	CcSEcCtD
Carfilzomib—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.00174	0.00403	CcSEcCtD
Carfilzomib—Pain—Montelukast—chronic obstructive pulmonary disease	0.00173	0.00401	CcSEcCtD
Carfilzomib—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.00173	0.00401	CcSEcCtD
Carfilzomib—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00173	0.004	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.00172	0.00399	CcSEcCtD
Carfilzomib—Headache—Aminophylline—chronic obstructive pulmonary disease	0.0017	0.00394	CcSEcCtD
Carfilzomib—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.0017	0.00393	CcSEcCtD
Carfilzomib—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00169	0.00392	CcSEcCtD
Carfilzomib—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00168	0.0039	CcSEcCtD
Carfilzomib—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00167	0.00387	CcSEcCtD
Carfilzomib—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00167	0.00387	CcSEcCtD
Carfilzomib—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00163	0.00379	CcSEcCtD
Carfilzomib—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00163	0.00379	CcSEcCtD
Carfilzomib—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00163	0.00377	CcSEcCtD
Carfilzomib—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00161	0.00374	CcSEcCtD
Carfilzomib—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00161	0.00372	CcSEcCtD
Carfilzomib—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.0016	0.00371	CcSEcCtD
Carfilzomib—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.00157	0.00365	CcSEcCtD
Carfilzomib—PSMB8—Fluorometholone—Prednisone—chronic obstructive pulmonary disease	0.00155	0.0745	CbGdCrCtD
Carfilzomib—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00154	0.00358	CcSEcCtD
Carfilzomib—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00152	0.00353	CcSEcCtD
Carfilzomib—PSMB8—Fluorometholone—Prednisolone—chronic obstructive pulmonary disease	0.00151	0.0727	CbGdCrCtD
Carfilzomib—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.00151	0.00349	CcSEcCtD
Carfilzomib—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00148	0.00344	CcSEcCtD
Carfilzomib—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00148	0.00344	CcSEcCtD
Carfilzomib—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00145	0.00337	CcSEcCtD
Carfilzomib—ABCB1—lung—chronic obstructive pulmonary disease	0.00144	0.0044	CbGeAlD
Carfilzomib—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00142	0.00328	CcSEcCtD
Carfilzomib—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00142	0.00328	CcSEcCtD
Carfilzomib—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.0014	0.00325	CcSEcCtD
Carfilzomib—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00139	0.00321	CcSEcCtD
Carfilzomib—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00137	0.00317	CcSEcCtD
Carfilzomib—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00137	0.00317	CcSEcCtD
Carfilzomib—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00134	0.0031	CcSEcCtD
Carfilzomib—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.00134	0.0031	CcSEcCtD
Carfilzomib—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00134	0.00309	CcSEcCtD
Carfilzomib—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00131	0.00305	CcSEcCtD
Carfilzomib—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00131	0.00305	CcSEcCtD
Carfilzomib—Headache—Arformoterol—chronic obstructive pulmonary disease	0.0013	0.003	CcSEcCtD
Carfilzomib—Headache—Formoterol—chronic obstructive pulmonary disease	0.0013	0.003	CcSEcCtD
Carfilzomib—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00129	0.00299	CcSEcCtD
Carfilzomib—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.00129	0.00299	CcSEcCtD
Carfilzomib—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00129	0.00298	CcSEcCtD
Carfilzomib—Headache—Montelukast—chronic obstructive pulmonary disease	0.00127	0.00294	CcSEcCtD
Carfilzomib—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.00126	0.00291	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.00125	0.0029	CcSEcCtD
Carfilzomib—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00124	0.00288	CcSEcCtD
Carfilzomib—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00123	0.00285	CcSEcCtD
Carfilzomib—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00123	0.00285	CcSEcCtD
Carfilzomib—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00122	0.00283	CcSEcCtD
Carfilzomib—Nausea—Montelukast—chronic obstructive pulmonary disease	0.0012	0.00279	CcSEcCtD
Carfilzomib—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.00118	0.00274	CcSEcCtD
Carfilzomib—PSMB8—Diflorasone—Prednisone—chronic obstructive pulmonary disease	0.00118	0.0567	CbGdCrCtD
Carfilzomib—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00116	0.00269	CcSEcCtD
Carfilzomib—PSMB8—Diflorasone—Prednisolone—chronic obstructive pulmonary disease	0.00115	0.0554	CbGdCrCtD
Carfilzomib—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.00101	0.00235	CcSEcCtD
Carfilzomib—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000958	0.00222	CcSEcCtD
Carfilzomib—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000922	0.00213	CcSEcCtD
Carfilzomib—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000861	0.00199	CcSEcCtD
Carfilzomib—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000849	0.00197	CcSEcCtD
Carfilzomib—Infection—Prednisone—chronic obstructive pulmonary disease	0.000809	0.00187	CcSEcCtD
Carfilzomib—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000776	0.0018	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000742	0.00172	CcSEcCtD
Carfilzomib—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000741	0.00172	CcSEcCtD
Carfilzomib—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000736	0.0017	CcSEcCtD
Carfilzomib—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000708	0.00164	CcSEcCtD
Carfilzomib—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000702	0.00163	CcSEcCtD
Carfilzomib—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000702	0.00163	CcSEcCtD
Carfilzomib—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000696	0.00161	CcSEcCtD
Carfilzomib—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000665	0.00154	CcSEcCtD
Carfilzomib—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000643	0.00149	CcSEcCtD
Carfilzomib—PSMB8—Betamethasone—Prednisone—chronic obstructive pulmonary disease	0.000632	0.0304	CbGdCrCtD
Carfilzomib—PSMB8—Dexamethasone—Prednisone—chronic obstructive pulmonary disease	0.000632	0.0304	CbGdCrCtD
Carfilzomib—PSMB8—Dexamethasone—Prednisolone—chronic obstructive pulmonary disease	0.000617	0.0297	CbGdCrCtD
Carfilzomib—PSMB8—Betamethasone—Prednisolone—chronic obstructive pulmonary disease	0.000617	0.0297	CbGdCrCtD
Carfilzomib—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000584	0.00135	CcSEcCtD
Carfilzomib—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000557	0.00129	CcSEcCtD
Carfilzomib—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000538	0.00125	CcSEcCtD
Carfilzomib—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000517	0.0012	CcSEcCtD
Carfilzomib—Headache—Prednisone—chronic obstructive pulmonary disease	0.00051	0.00118	CcSEcCtD
Carfilzomib—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000483	0.00112	CcSEcCtD
Carfilzomib—PSMB9—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000212	0.00103	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—CTGF—chronic obstructive pulmonary disease	0.00021	0.00102	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—TLR4—chronic obstructive pulmonary disease	0.000207	0.00101	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—TLR4—chronic obstructive pulmonary disease	0.000206	0.001	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000204	0.000989	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000203	0.000985	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000199	0.000964	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000198	0.00096	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000198	0.000959	CbGpPWpGaD
Carfilzomib—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	0.000197	0.000955	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000197	0.000954	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000197	0.000954	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000197	0.000954	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000194	0.00094	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—CD8A—chronic obstructive pulmonary disease	0.000193	0.000935	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—CD8A—chronic obstructive pulmonary disease	0.000193	0.000935	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—CD8A—chronic obstructive pulmonary disease	0.000193	0.000935	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—CD8A—chronic obstructive pulmonary disease	0.00019	0.000922	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000189	0.000914	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000188	0.000913	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000188	0.00091	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000187	0.000909	CbGpPWpGaD
Carfilzomib—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	0.000184	0.000892	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—NOS2—chronic obstructive pulmonary disease	0.000182	0.000883	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—NOS2—chronic obstructive pulmonary disease	0.000181	0.000879	CbGpPWpGaD
Carfilzomib—PSMB8—Cytokine Signaling in Immune system—IL6—chronic obstructive pulmonary disease	0.000181	0.000876	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—ERBB3—chronic obstructive pulmonary disease	0.000179	0.000869	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—ERBB3—chronic obstructive pulmonary disease	0.000179	0.000869	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—ERBB3—chronic obstructive pulmonary disease	0.000179	0.000869	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—ERBB3—chronic obstructive pulmonary disease	0.000177	0.000857	CbGpPWpGaD
Carfilzomib—PSMB10—Adaptive Immune System—EGFR—chronic obstructive pulmonary disease	0.00017	0.000822	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—EGFR—chronic obstructive pulmonary disease	0.000169	0.000818	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000168	0.000816	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000167	0.000812	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000166	0.000806	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000166	0.000806	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000166	0.000806	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—ERBB3—chronic obstructive pulmonary disease	0.000166	0.000803	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—ERBB3—chronic obstructive pulmonary disease	0.000166	0.000803	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—ERBB3—chronic obstructive pulmonary disease	0.000166	0.000803	CbGpPWpGaD
Carfilzomib—PSMB10—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	0.000165	0.000801	CbGpPWpGaD
Carfilzomib—PSMB9—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	0.000164	0.000797	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000164	0.000795	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000164	0.000795	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000164	0.000795	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000164	0.000795	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—CRP—chronic obstructive pulmonary disease	0.000164	0.000795	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—CRP—chronic obstructive pulmonary disease	0.000164	0.000795	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—CRP—chronic obstructive pulmonary disease	0.000164	0.000795	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—ERBB3—chronic obstructive pulmonary disease	0.000163	0.000791	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000162	0.000784	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000162	0.000784	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000162	0.000784	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000162	0.000784	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—CRP—chronic obstructive pulmonary disease	0.000162	0.000784	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.00016	0.000773	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—TLR4—chronic obstructive pulmonary disease	0.000157	0.000762	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—TLR4—chronic obstructive pulmonary disease	0.000157	0.000762	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—TLR4—chronic obstructive pulmonary disease	0.000157	0.000762	CbGpPWpGaD
Carfilzomib—PSMB10—Cell Cycle—TP53—chronic obstructive pulmonary disease	0.000155	0.000753	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—TLR4—chronic obstructive pulmonary disease	0.000155	0.000751	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000155	0.00075	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000155	0.00075	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000155	0.00075	CbGpPWpGaD
Carfilzomib—PSMB9—Cell Cycle—TP53—chronic obstructive pulmonary disease	0.000155	0.00075	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—SERPINE1—chronic obstructive pulmonary disease	0.000153	0.000744	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000153	0.000742	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—SERPINE1—chronic obstructive pulmonary disease	0.000153	0.00074	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000152	0.000739	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000152	0.000738	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000151	0.000731	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000151	0.000731	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000151	0.000731	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000149	0.000721	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.000147	0.000714	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.000147	0.00071	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—NOS3—chronic obstructive pulmonary disease	0.000146	0.00071	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—NOS3—chronic obstructive pulmonary disease	0.000146	0.000706	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000143	0.000693	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000143	0.000693	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000143	0.000693	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000143	0.000692	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000143	0.000692	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000143	0.000692	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000141	0.000683	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000141	0.000682	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—NOS2—chronic obstructive pulmonary disease	0.000138	0.000669	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—NOS2—chronic obstructive pulmonary disease	0.000138	0.000669	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—NOS2—chronic obstructive pulmonary disease	0.000138	0.000669	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.000137	0.000664	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.000136	0.00066	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—NOS2—chronic obstructive pulmonary disease	0.000136	0.00066	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—IL1B—chronic obstructive pulmonary disease	0.000135	0.000654	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—IL1B—chronic obstructive pulmonary disease	0.000134	0.000651	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000131	0.000635	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—EGFR—chronic obstructive pulmonary disease	0.000128	0.000623	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—EGFR—chronic obstructive pulmonary disease	0.000128	0.000623	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—EGFR—chronic obstructive pulmonary disease	0.000128	0.000623	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—ALB—chronic obstructive pulmonary disease	0.000128	0.000621	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—ALB—chronic obstructive pulmonary disease	0.000128	0.000619	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000128	0.000618	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000128	0.000618	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000128	0.000618	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	0.000127	0.000618	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—EGFR—chronic obstructive pulmonary disease	0.000127	0.000614	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000126	0.00061	CbGpPWpGaD
Carfilzomib—PSMB1—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	0.000125	0.000607	CbGpPWpGaD
Carfilzomib—PSMB5—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	0.000125	0.000607	CbGpPWpGaD
Carfilzomib—PSMB2—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	0.000125	0.000607	CbGpPWpGaD
Carfilzomib—PSMB8—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	0.000123	0.000598	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000123	0.000594	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000122	0.000592	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000118	0.000574	CbGpPWpGaD
Carfilzomib—PSMB5—Cell Cycle—TP53—chronic obstructive pulmonary disease	0.000118	0.000571	CbGpPWpGaD
Carfilzomib—PSMB1—Cell Cycle—TP53—chronic obstructive pulmonary disease	0.000118	0.000571	CbGpPWpGaD
Carfilzomib—PSMB2—Cell Cycle—TP53—chronic obstructive pulmonary disease	0.000118	0.000571	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—SERPINE1—chronic obstructive pulmonary disease	0.000116	0.000563	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—SERPINE1—chronic obstructive pulmonary disease	0.000116	0.000563	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—SERPINE1—chronic obstructive pulmonary disease	0.000116	0.000563	CbGpPWpGaD
Carfilzomib—PSMB8—Cell Cycle—TP53—chronic obstructive pulmonary disease	0.000116	0.000563	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000116	0.000562	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000116	0.000562	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000116	0.000562	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—SERPINE1—chronic obstructive pulmonary disease	0.000115	0.000556	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000114	0.000554	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.000112	0.000541	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.000112	0.000541	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.000112	0.000541	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—NOS3—chronic obstructive pulmonary disease	0.000111	0.000538	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—NOS3—chronic obstructive pulmonary disease	0.000111	0.000538	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—NOS3—chronic obstructive pulmonary disease	0.000111	0.000538	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.00011	0.000533	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—NOS3—chronic obstructive pulmonary disease	0.000109	0.00053	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	0.000107	0.000521	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	0.000107	0.000518	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	0.000106	0.000513	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.000104	0.000503	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.000104	0.000503	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.000104	0.000503	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—EGFR—chronic obstructive pulmonary disease	0.000103	0.000498	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	0.000103	0.000497	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—EGFR—chronic obstructive pulmonary disease	0.000102	0.000496	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—IL1B—chronic obstructive pulmonary disease	0.000102	0.000496	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—IL1B—chronic obstructive pulmonary disease	0.000102	0.000496	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—IL1B—chronic obstructive pulmonary disease	0.000102	0.000496	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.000102	0.000496	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	0.000102	0.000495	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000102	0.000493	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—IL1B—chronic obstructive pulmonary disease	0.000101	0.000489	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	9.72e-05	0.000471	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—ALB—chronic obstructive pulmonary disease	9.71e-05	0.000471	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—ALB—chronic obstructive pulmonary disease	9.71e-05	0.000471	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—ALB—chronic obstructive pulmonary disease	9.71e-05	0.000471	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—TGFB1—chronic obstructive pulmonary disease	9.68e-05	0.000469	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—TGFB1—chronic obstructive pulmonary disease	9.64e-05	0.000467	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—ALB—chronic obstructive pulmonary disease	9.58e-05	0.000464	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	9.53e-05	0.000462	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—EGFR—chronic obstructive pulmonary disease	9.49e-05	0.00046	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—EGFR—chronic obstructive pulmonary disease	9.45e-05	0.000458	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—NOS3—chronic obstructive pulmonary disease	9.29e-05	0.000451	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—NOS3—chronic obstructive pulmonary disease	9.29e-05	0.000451	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—NOS3—chronic obstructive pulmonary disease	9.29e-05	0.000451	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—NOS3—chronic obstructive pulmonary disease	9.16e-05	0.000444	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	9.09e-05	0.000441	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	9.08e-05	0.00044	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	9.05e-05	0.000439	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	8.23e-05	0.000399	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	8.19e-05	0.000397	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.14e-05	0.000395	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.14e-05	0.000395	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.14e-05	0.000395	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.02e-05	0.000389	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	8e-05	0.000388	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—IL6—chronic obstructive pulmonary disease	7.9e-05	0.000383	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—IL6—chronic obstructive pulmonary disease	7.86e-05	0.000381	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—EGFR—chronic obstructive pulmonary disease	7.79e-05	0.000378	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—EGFR—chronic obstructive pulmonary disease	7.79e-05	0.000378	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—EGFR—chronic obstructive pulmonary disease	7.79e-05	0.000378	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.77e-05	0.000377	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.77e-05	0.000377	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.77e-05	0.000377	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—EGFR—chronic obstructive pulmonary disease	7.68e-05	0.000372	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.66e-05	0.000371	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	7.39e-05	0.000358	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	7.35e-05	0.000356	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—TGFB1—chronic obstructive pulmonary disease	7.34e-05	0.000356	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—TGFB1—chronic obstructive pulmonary disease	7.34e-05	0.000356	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—TGFB1—chronic obstructive pulmonary disease	7.34e-05	0.000356	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—IL6—chronic obstructive pulmonary disease	7.3e-05	0.000354	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—IL6—chronic obstructive pulmonary disease	7.26e-05	0.000352	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—TGFB1—chronic obstructive pulmonary disease	7.23e-05	0.000351	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—EGFR—chronic obstructive pulmonary disease	7.19e-05	0.000349	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—EGFR—chronic obstructive pulmonary disease	7.19e-05	0.000349	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—EGFR—chronic obstructive pulmonary disease	7.19e-05	0.000349	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—EGFR—chronic obstructive pulmonary disease	7.09e-05	0.000344	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.96e-05	0.000338	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.89e-05	0.000334	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.89e-05	0.000334	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.89e-05	0.000334	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	6.88e-05	0.000334	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.8e-05	0.000329	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	6.78e-05	0.000329	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	6.75e-05	0.000327	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	6.65e-05	0.000322	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	6.62e-05	0.000321	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	6.28e-05	0.000305	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.23e-05	0.000302	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.23e-05	0.000302	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.23e-05	0.000302	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.15e-05	0.000298	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.1e-05	0.000296	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—IL6—chronic obstructive pulmonary disease	5.99e-05	0.00029	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—IL6—chronic obstructive pulmonary disease	5.99e-05	0.00029	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—IL6—chronic obstructive pulmonary disease	5.99e-05	0.00029	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—IL6—chronic obstructive pulmonary disease	5.9e-05	0.000286	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.79e-05	0.000281	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.6e-05	0.000271	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.6e-05	0.000271	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.6e-05	0.000271	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.58e-05	0.000271	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.55e-05	0.000269	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—IL6—chronic obstructive pulmonary disease	5.53e-05	0.000268	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—IL6—chronic obstructive pulmonary disease	5.53e-05	0.000268	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—IL6—chronic obstructive pulmonary disease	5.53e-05	0.000268	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.52e-05	0.000268	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—IL6—chronic obstructive pulmonary disease	5.45e-05	0.000264	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.14e-05	0.000249	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.14e-05	0.000249	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.14e-05	0.000249	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—IL6—chronic obstructive pulmonary disease	5.11e-05	0.000248	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—IL6—chronic obstructive pulmonary disease	5.08e-05	0.000247	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.07e-05	0.000246	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.04e-05	0.000244	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.04e-05	0.000244	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.04e-05	0.000244	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.97e-05	0.000241	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.83e-05	0.000234	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.76e-05	0.000231	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.44e-05	0.000215	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.23e-05	0.000205	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.23e-05	0.000205	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.23e-05	0.000205	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.2e-05	0.000204	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.17e-05	0.000202	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.87e-05	0.000188	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.87e-05	0.000188	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.87e-05	0.000188	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.82e-05	0.000185	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	2.86e-05	0.000139	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.73e-05	0.000133	CbGpPWpGaD
